BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 30825395)

  • 41. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
    Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
    J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Randomized controlled trial of storytelling compared to a personal risk tool intervention on colorectal cancer screening in low-income patients.
    Larkey LK; McClain D; Roe DJ; Hector RD; Lopez AM; Sillanpaa B; Gonzalez J
    Am J Health Promot; 2015; 30(2):e59-70. PubMed ID: 25615708
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of different strategies used to invite subjects with a positive faecal occult blood test to a colonoscopy assessment. A randomised controlled trial in population-based screening programmes.
    Zorzi M; Giorgi Rossi P; Cogo C; Falcini F; Giorgi D; Grazzini G; Mariotti L; Matarese V; Soppelsa F; Senore C; Ferro A;
    Prev Med; 2014 Aug; 65():70-6. PubMed ID: 24811759
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Text Message Preferences for Surveillance Colonoscopy Reminders Among Colorectal Cancer Survivors.
    Hohl SD; Shankaran V; Bell-Brown A; Issaka RB
    Health Educ Behav; 2020 Aug; 47(4):581-591. PubMed ID: 32449386
    [No Abstract]   [Full Text] [Related]  

  • 46. Cost-effectiveness of patient mailings to promote colorectal cancer screening.
    Sequist TD; Franz C; Ayanian JZ
    Med Care; 2010 Jun; 48(6):553-7. PubMed ID: 20473196
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mobile messenger-initiated reminders improve longitudinal adherence in a community-based, opportunistic colorectal cancer screening program: A single-blind, crossover randomized controlled study.
    Lam TYT; Wu PI; Tang RSY; Luk AKC; Ng S; Sung JJY
    Cancer; 2021 Mar; 127(6):914-921. PubMed ID: 33216357
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Analysis of community colorectal cancer screening in 50-74 years old people in Guangzhou, 2015-2016].
    Li Y; Liu HZ; Liang YR; Lin GZ; Li K; Dong H; Xu H; Wang M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jan; 39(1):81-85. PubMed ID: 29374902
    [No Abstract]   [Full Text] [Related]  

  • 50. Financial Incentives to Increase Colorectal Cancer Screening Uptake and Decrease Disparities: A Randomized Clinical Trial.
    Green BB; Anderson ML; Cook AJ; Chubak J; Fuller S; Kimbel KJ; Kullgren JT; Meenan RT; Vernon SW
    JAMA Netw Open; 2019 Jul; 2(7):e196570. PubMed ID: 31276178
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spiritually based intervention to increase colorectal cancer screening among African Americans: screening and theory-based outcomes from a randomized trial.
    Holt CL; Litaker MS; Scarinci IC; Debnam KJ; McDavid C; McNeal SF; Eloubeidi MA; Crowther M; Bolland J; Martin MY
    Health Educ Behav; 2013 Aug; 40(4):458-68. PubMed ID: 23033548
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Application of short message service to control blood cholesterol: a field trial.
    Sadeghian S; Shams M; Alipour Z; Saadat S; Hamidian R; Shahrzad M
    BMC Med Inform Decis Mak; 2017 Mar; 17(1):32. PubMed ID: 28351408
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Testing the effectiveness of a general practice intervention to improve uptake of colorectal cancer screening: a randomised controlled trial.
    Dodd N; Carey M; Mansfield E; Oldmeadow C; Evans TJ
    Aust N Z J Public Health; 2019 Oct; 43(5):464-469. PubMed ID: 31268211
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The NordICC Study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer.
    Kaminski MF; Bretthauer M; Zauber AG; Kuipers EJ; Adami HO; van Ballegooijen M; Regula J; van Leerdam M; Stefansson T; Påhlman L; Dekker E; Hernán MA; Garborg K; Hoff G
    Endoscopy; 2012 Jul; 44(7):695-702. PubMed ID: 22723185
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adherence to national guidelines for colorectal cancer screening in Israel: Comprehensive multi-year assessment based on electronic medical records.
    Paltiel O; Keidar Tirosh A; Paz Stostky O; Calderon-Margalit R; Cohen AD; Elran E; Valinsky L; Matz E; Krieger M; Yehuda AB; Jaffe DH; Manor O
    J Med Screen; 2021 Mar; 28(1):25-33. PubMed ID: 32356670
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sociocultural and health correlates related to colorectal cancer screening adherence among urban African Americans.
    Brittain K; Murphy VP
    Cancer Nurs; 2015; 38(2):118-24. PubMed ID: 24836955
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors Influencing Adherence to Recommended Colorectal Cancer Surveillance: Experiences and Behaviors of Colorectal Cancer Survivors.
    Ford ME; Sterba KR; Armeson K; Malek AM; Knight KD; Zapka J
    J Cancer Educ; 2019 Oct; 34(5):938-949. PubMed ID: 30073494
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patterns of participation over four rounds of annual fecal immunochemical test-based screening for colorectal cancer: what predicts rescreening?
    Osborne JM; Wilson C; Duncan A; Cole SR; Flight I; Turnbull D; Hughes DL; Young GP
    BMC Public Health; 2017 Aug; 18(1):81. PubMed ID: 28764667
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increasing participation in colorectal cancer screening: results from a cluster randomized trial of directly mailed gFOBT kits to previous nonresponders.
    Tinmouth J; Patel J; Austin PC; Baxter NN; Brouwers MC; Earle C; Levitt C; Lu Y; Mackinnon M; Paszat L; Rabeneck L
    Int J Cancer; 2015 Mar; 136(6):E697-703. PubMed ID: 25195923
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Implementation intentions and colorectal screening: a randomized trial in safety-net clinics.
    Greiner KA; Daley CM; Epp A; James A; Yeh HW; Geana M; Born W; Engelman KK; Shellhorn J; Hester CM; LeMaster J; Buckles DC; Ellerbeck EF
    Am J Prev Med; 2014 Dec; 47(6):703-14. PubMed ID: 25455115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.